Cytosorbents Corp
CTSO
69 hedge funds and large institutions have $42.5M invested in Cytosorbents Corp in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 12 closing their positions.
15% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 20
0.25% less ownership
Funds ownership: 26.41% → 26.16% (-0.25%)
4% less funds holding
Funds holding: 72 → 69 (-3)
24% less capital invested
Capital invested by funds: $56.3M → $42.5M (-$13.8M)
25% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 12
95% less call options, than puts
Call options by funds: $8K | Put options by funds: $177K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$1.56M |
| 2 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
+$545K |
| 3 |
NIM
NXG Investment Management
Dallas,
Texas
|
+$412K |
| 4 |
BlackRock
New York
|
+$303K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$297K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$2.17M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
-$1.16M |
| 3 |
BFS
Bradley Foster & Sargent
Hartford,
Connecticut
|
-$426K |
| 4 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
-$221K |
| 5 |
D.E. Shaw & Co
New York
|
-$164K |
CTSO Hedge Fund Activity: Q3 2019 in Review
69 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q3 2019, worth a combined $42.5M — down 24% from $56.3M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of CTSO and 9 opened new positions — a net loss of 3 holders — while 20 trimmed existing stakes and 23 added.
The largest buyer was Granahan Investment Management, adding an estimated $1.56M. The largest seller was United Services Automobile Association, exiting entirely with an estimated $2.17M sold.
- 69 institutional investors held Cytosorbents Corp (CTSO) as of Q3 2019, down from 72 in Q2 2019.
- Funds reported $42.5M of Cytosorbents Corp stock for Q3 2019, down 24% quarter-over-quarter.
- 9 funds opened new Cytosorbents Corp positions in Q3 2019 and 12 closed out, a net change of -3 holders.
- The largest Cytosorbents Corp buyer in Q3 2019 was Granahan Investment Management, an estimated $1.56M added.
- The largest Cytosorbents Corp seller in Q3 2019 was United Services Automobile Association, an estimated $2.17M sold.
Based on aggregated 13F filings for Q3 2019.